Current elimination status of hepatitis C virus‐infected maintenance hemodialysis patients in Iwate Prefecture, Japan
Therapeutic Apheresis and Dialysis · 2023
DOI: 10.1111/1744-9987.13999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2023. Verfasst von Akio Miyasaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, School of Medicine, Shiwa-gun, Japan. Hauptthemen laut MEDLINE: Hepatitis C, Hepatitis C, Chronic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japanese Ministry of Health, Labour, and Welfare.
Abstract (Originalsprache)
Introduction
The aim is to clarify the hepatitis C virus (HCV) status of hemodialysis (HD) patients and patient management after HCV elimination.
Methods
Questionnaire survey was conducted in Iwate prefecture, Japan from 2016 to 2021.
Results
Patients underwent HD was 2944, including 132 anti‐HCV antibody‐positive patients, with 91 HCV RNA‐positive patients. Of the 91 HCV RNA‐positive patients, 51 received antiviral treatment. Sustained virological response (SVR) rate was 94%. The patients treated with direct antiviral agents had significantly lower mortality rate than the untreated patients, and no liver‐related deaths occurred in patients who achieved SVR or in HCV RNA‐negative patients. The HCV RNA‐positive prevalence was finally 0.79%. Approximately 40% of the facilities had dedicated beds and dialysis‐related items for patients who achieved an SVR.
Conclusion
To eliminate HCV in HD facilities, it is necessary to promote HCV RNA testing for anti‐HCV antibody‐positive patients and to provide antiviral treatment for HCV RNA‐positive patients. Additionally, collaboration among hepatologists and HD specialists are essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, School of Medicine, Shiwa-gun, Japan.
- Department of Urology, Iwate Medical University, School of Medicine, Shiwa-gun, Japan.
ORCID-Profile: Akio Miyasaka, Keisuke Kakisaka, Takaya Abe
Förderung
- Japanese Ministry of Health, Labour, and Welfare
Zitieren
APA
Miyasaka, A., Yoshida, Y., Suzuki, A., Endo, K., Kakisaka, K., Oikawa, T., Abe, T., Obara, W., & Matsumoto, T. (2023). Current elimination status of hepatitis C virus‐infected maintenance hemodialysis patients in Iwate Prefecture, Japan. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.13999
Vancouver
Miyasaka A, Yoshida Y, Suzuki A, Endo K, Kakisaka K, Oikawa T, et al. Current elimination status of hepatitis C virus‐infected maintenance hemodialysis patients in Iwate Prefecture, Japan. Therapeutic Apheresis and Dialysis. 2023. doi:10.1111/1744-9987.13999
BibTeX
@article{Miyasaka2023,
author = {Miyasaka, Akio and Yoshida, Yuichi and Suzuki, Akiko and Endo, Kei and Kakisaka, Keisuke and Oikawa, Takayoshi and Abe, Takaya and Obara, Wataru and Matsumoto, Takayuki},
title = {Current elimination status of hepatitis C virus‐infected maintenance hemodialysis patients in Iwate Prefecture, Japan},
journal = {Therapeutic Apheresis and Dialysis},
year = {2023},
doi = {10.1111/1744-9987.13999}
}
EUVIMED